Why India needs more research-based life sciences companies
Is the Indian generic pharmaceutical industry one of the major obstacles to fighting endemic health problems in the country? You may begin to think so after reading this article written by Kiran Mazumdar-Shaw in the Economic Times. Ms Mazmudar-Shaw…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.